tiprankstipranks
Advertisement
Advertisement

AXGN Stock Latest News

AxoGen price target raised to $55 from $50 at Jefferies
The FlyAxoGen price target raised to $55 from $50 at Jefferies
3d ago
AXGN
AxoGen price target raised to $55 from $50 at Canaccord
PremiumThe Fly
AxoGen price target raised to $55 from $50 at Canaccord
3d ago
AXGN
AxoGen price target raised to $53 from $50 at H.C. Wainwright
PremiumThe Fly
AxoGen price target raised to $53 from $50 at H.C. Wainwright
3d ago
AXGN
AxoGen price target raised to $55 from $50 at Citizens
PremiumThe Fly
AxoGen price target raised to $55 from $50 at Citizens
3d ago
AXGN
AxoGen price target raised to $55 from $50 at Jefferies
PremiumThe Fly
AxoGen price target raised to $55 from $50 at Jefferies
4d ago
AXGN
AxoGen reports Q2 adjusted EPS 12c, consensus 12c
PremiumThe FlyAxoGen reports Q2 adjusted EPS 12c, consensus 12c
4d ago
AXGN
AxoGen raises FY26 revenue view to $279M from $270M, consensus $270.92M
Premium
The Fly
AxoGen raises FY26 revenue view to $279M from $270M, consensus $270.92M
4d ago
AXGN
AxoGen boosts outlook after strong second-quarter growth
Premium
Company Announcements
AxoGen boosts outlook after strong second-quarter growth
4d ago
8K
AXGN
Trace Biosciences announces strategic investment from Axogen
PremiumThe Fly
Trace Biosciences announces strategic investment from Axogen
4d ago
AXGN
Is AXGN a Buy, Before Earnings?
PremiumPre-Earnings
Is AXGN a Buy, Before Earnings?
6d ago
AXGN
Neuronetics appoints Nir Naor as CFO, CLO Andrew Macan to step down
PremiumThe Fly
Neuronetics appoints Nir Naor as CFO, CLO Andrew Macan to step down
13d ago
AXGN
STIM
AxoGen Shareholders Approve Directors, Auditor and Executive Pay
PremiumCompany Announcements
AxoGen Shareholders Approve Directors, Auditor and Executive Pay
1M ago
8K
AXGN
AxoGen’s New Head-to-Head Nerve Repair Study Puts Avance Graft Under the Spotlight
PremiumCompany AnnouncementsAxoGen’s New Head-to-Head Nerve Repair Study Puts Avance Graft Under the Spotlight
1M ago
AXGN
AxoGen price target raised to $48 from $41 at Raymond James
Premium
The Fly
AxoGen price target raised to $48 from $41 at Raymond James
3M ago
AXGN
AxoGen price target raised to $50 from $45 at Canaccord
Premium
The Fly
AxoGen price target raised to $50 from $45 at Canaccord
3M ago
AXGN
AxoGen price target raised to $50 from $39 at H.C. Wainwright
PremiumThe Fly
AxoGen price target raised to $50 from $39 at H.C. Wainwright
3M ago
AXGN
AxoGen price target raised to $50 from $42 at Citizens
PremiumThe Fly
AxoGen price target raised to $50 from $42 at Citizens
3M ago
AXGN
AxoGen rises 12.8%
PremiumThe Fly
AxoGen rises 12.8%
3M ago
AXGN
AxoGen raises FY26 revenue view to $270M from $265.7M, consensus $265.89M
PremiumThe Fly
AxoGen raises FY26 revenue view to $270M from $265.7M, consensus $265.89M
3M ago
AXGN
AxoGen Delivers Strong Q1 Growth and Raises 2026 Outlook
PremiumCompany AnnouncementsAxoGen Delivers Strong Q1 Growth and Raises 2026 Outlook
3M ago
8K
AXGN
AxoGen reports Q1 adjusted EPS 7c, consensus 7c
Premium
The Fly
AxoGen reports Q1 adjusted EPS 7c, consensus 7c
3M ago
AXGN
Is AXGN a Buy, Before Earnings?
Premium
Pre-Earnings
Is AXGN a Buy, Before Earnings?
3M ago
AXGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >